Cargando…
Analytic validation and clinical utilization of the comprehensive genomic profiling test, GEM ExTra(®)
We developed and analytically validated a comprehensive genomic profiling (CGP) assay, GEM ExTra, for patients with advanced solid tumors that uses Next Generation Sequencing (NGS) to characterize whole exomes employing a paired tumor-normal subtraction methodology. The assay detects single nucleoti...
Autores principales: | White, Tracey, Szelinger, Szabolcs, LoBello, Janine, King, Amy, Aldrich, Jessica, Garinger, Nathan, Halbert, Matthew, Richholt, Ryan F., Mastrian, Stephen D., Babb, Cody, Ozols, Audrey A., Goodman, Laurie J., Basu, Gargi D., Royce, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057276/ https://www.ncbi.nlm.nih.gov/pubmed/33889297 http://dx.doi.org/10.18632/oncotarget.27945 |
Ejemplares similares
-
The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series
por: Drenner, Kevin, et al.
Publicado: (2021) -
Addendum: The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series
por: Drenner, Kevin, et al.
Publicado: (2022) -
A Case Report of Immunotherapy-Resistant MSI-H Gastric Cancer with Significant Intrapatient Tumoral Heterogeneity Characterized by Histologic Dedifferentiation
por: Kethireddy, Nikhila, et al.
Publicado: (2022) -
Underreporting of SMARCB1 alteration by clinical sequencing: Integrative patho-genomic analysis captured SMARCB1/INI-1 deficiency in a vulvar yolk sac tumor
por: Wei, Christina H., et al.
Publicado: (2023) -
Association with the nonparoxysmal atrial fibrillation duration and outcome of ExTRa Mapping‐guided rotor ablation
por: Okuyama, Yusuke, et al.
Publicado: (2023)